Prenatal opioid exposure in babies doesn't predict future classroom performance, study finds

Every 25 minutes in the United States, a baby is diagnosed with neonatal abstinence syndrome (NAS), a condition that occurs in newborns who have been exposed to opioids in the womb and develop withdrawal after birth, according to the Centers for Disease Control and Prevention. Historically, research has focused on the impact of NAS—also known as neonatal opioid withdrawal syndrome—on the health and development of young children, which has found that prenatal opioid exposure is associated with increased risk for adverse developmental, cognitive and behavioral outcomes in early childhood.